Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on PURETECH HEALTH PLC
01/03 PURETECH HEALTH : Affiliate resTORbio Adds Lynne Sullivan, Biogen Senior Vice Pr..
01/03 PURETECH HEALTH : resTORbio Appoints Lynne Sullivan to Its Board of Directors
01/02 PURETECH HEALTH : Affiliate resTORbio Files Public Registration Statement for Pr..
2017 PURETECH HEALTH : Affiliate Entrega to Receive $5 Million for Eli Lilly Collabor..
2017 PURETECH HEALTH : Entrega To Receive $5 Million Investment from Lilly To Advance..
2017 ENTREGA : To Receive $5 Million Investment from Lilly To Advance Proprietary Ora..
2017 PURETECH HEALTH : Vedanta Biosciences Granted Four New US Patents Expanding Cove..
2017 VEDANTA BIOSCIENCES : Granted Four New U.S. Patents Expanding Coverage for Compo..
2017 PURETECH HEALTH : resTORbio Appoints Paul Fonteyne to Its Board of Directors
2017 PURETECH HEALTH : Affiliate resTORbio Adds Paul Fonteyne, CEO of Boehringer Inge..
2017 PURETECH HEALTH : Microbiome Programme Advances into a Phase 1a/1b Clinical Tria..
2017 VEDANTA BIOSCIENCES : Announces Initiation of Phase 1a/1b Trial for New Drug Cla..
2017 PURETECH HEALTH : resTORbio Files Confidential Submission of Draft Registration ..
2017 PURETECH HEALTH : resTORbio Files Confidential Submission of Draft Registration ..
2017 PURETECH HEALTH : Akili Achieves Primary Endpoint in Pivotal Study of Investigat..
2017 PURETECH HEALTH : Akili Achieves Primary Efficacy Endpoint in Pediatric ADHD Piv..
2017 PURETECH HEALTH : PureTechs Vedanta Biosciences expands clinical, translational ..
2017 PURETECH HEALTH : resTORbio Raises $40 Million from Leading Biotech and Institut..
2017 PURETECH HEALTH : Vedanta Biosciences Expands Clinical Translational Collaborati..
2017 VEDANTA BIOSCIENCES : Expands Network of Clinical Collaborations Supporting Deve..
2017 PURETECH HEALTH : to Present at Piper Jaffray 2017 Healthcare Conference
2017 PURETECH HEALTH : resTORbio Advances Immunotherapy Candidate for Aging-Related C..
2017 PURETECH HEALTH : Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to ..
2017 PURETECH HEALTH : to Present at Jefferies 2017 Healthcare Conference in London
2017 PURETECH HEALTH : Vedanta Biosciences Awarded $5.4 Million Grant from Combating ..
2017 VEDANTA BIOSCIENCES : Awarded Up To $5.4 Million from CARB-X to Accelerate Devel..
2017 PURETECH HEALTH : Vedanta Licenses Microbiome-Derived Immuno-Oncology Product Ca..
2017 VEDANTA BIOSCIENCES : to Advance Cancer Immunotherapy Candidates Based on Microb..
2017 PURETECH HEALTH : Notes U.S. Patent Issuance Broadly Covering Methods of Assessi..
2017 GELESIS : 100 Achieves Significant Weight Loss with Excellent Safety Profile in ..
2017 PURETECH HEALTH : Gelesis Reports Significant Weight Loss with Excellent Safety ..
2017 PURETECH HEALTH : Notes US Patent Issuance Broadly Covering Methods of Assessing..
2017 PURETECH HEALTH : Notes U.S. Patent Issuance Broadly Covering Methods of Assessi..
2017 PURETECH HEALTH : Exclusively Licenses Glyph Technology from Monash University t..
2017 PURETECH HEALTH : Exclusively Licenses Glyph Technology from Monash University t..
2017PURETECH HEALTH PLC : half-yearly earnings release
2017 PURETECH HEALTH : Notice of Half-Yearly Results
2017 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
2017 PURETECH HEALTH : Gelesis Announces Last Patient Visit in the Pivotal Gelesis100..
2017 PURETECH HEALTH : Gelesis Announces Last Patient Out in the Pivotal Gelesis100 W..
2017 PURETECH HEALTH : Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chai..
2017 PURETECH HEALTH : Former Cubist CEO, DreamWorks Interactive CEO, and Google Chie..
2017 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
2017 PURETECH HEALTH : Vedanta Biosciences Granted U.S. Patent Broadly Covering Metho..
2017 VEDANTA BIOSCIENCES : Granted U.S. Patent Broadly Covering Methods of Treatment ..
2017 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
2017 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
2017 PURETECH HEALTH : Karuna to Present Tolerability Proof-of-Concept Data for KarXT..
2017 KARUNA PHARMACEUTICALS : to Present KarXT Tolerability Proof-of-Concept Data for..
2017 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
2017 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
2017 PURETECH HEALTH : Vedanta Biosciences Granted Three New U.S. Patents for Therape..
2017 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
2017 PURETECH HEALTH : Announces Licensing Agreement between Commense and the Univers..
2017 PURETECH HEALTH : Results of Annual General Meeting
2017 PURETECH HEALTH : Announces Licensing Agreement between Commense and the Univers..
2017 PURETECH HEALTH : Announces Initiation of Phase 2b mTORC1 Inhibitors Study in El..
2017 PURETECH HEALTH : UBC has Commonsense for licence
2017 PURETECH HEALTH : Announces Licensing Agreement between Commense and the Univers..
2017 GELESIS : Announces €2.9 Million Award from Italian Ministry of Economic Develop..
2017 CORRECT : PureTech Health's Chowrira Buys 34,000 Shares
2017 DIRECTOR DEALINGS : PureTech Health's Chowrira Buys 34,000 Shares
2017 PURETECH HEALTH : resTORbio Appoints Joan Mannick, M.D., as Chief Medical Office..
2017 PURETECH HEALTH : resTORbio Appoints Joan Mannick, M.D., as Chief Medical Office..
2017 PURETECH HEALTH : Advances New Programme Targeting Immunosuppressive Gamma Delta..
2017 PURETECH HEALTH : launches an I/O startup inspired by NYUs George Miller; SV ado..
2017 PURETECH HEALTH : Launches Pancreatic Cancer Treatment Programme
2017 PURETECH HEALTH : Advances New Program Targeting Immunosuppressive Gamma Delta T..
2017 PURETECH HEALTH : Akili Announces Results from a Project EVOTM Pilot Study Demon..
2017 PURETECH HEALTH : Announces Annual Results for Year Ended 31 December 2016
2017 PURETECH HEALTH : Loss Widens As It Progresses Development Programmes
2017 PURETECH HEALTH : Akili Announces Results from Pilot Study Showing Treatment wit..
2017 PURETECH HEALTH : Announces Licensing and Equity Agreement with Novartis to Adva..
2017 PURETECH HEALTH : and Novartis to advance clinical-stage programmes
2017 PURETECH HEALTH : Inks Deal With Novartis To Develop Ageing Disorder Therapies
1  2Next
Financials ($)
Sales 2017 1,58 M
EBIT 2017 -120 M
Net income 2017 -97,2 M
Finance 2017 23,9 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 342x
EV / Sales 2018 157x
Capitalization 562 M
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,42 $
Spread / Average Target 44%
EPS Revisions
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Eric Elenko Chief-Research & Strategy
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC15.00%562
CELLTRION, INC.--.--%41 248
IQVIA HOLDINGS INC2.19%20 807
LONZA GROUP0.42%20 432
INCYTE CORPORATION-0.68%19 852
ALNYLAM PHARMACEUTICALS, INC.1.59%12 692